Methylphenidate Hydrochloride 72865-0135-01
- Manufacturer
- Xlcare Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- February 24, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA211009
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 36 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
72865-0135-01Selected100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-135-01)